ÂÜÀòÂÒÂ×

Gismo Therapeutics is a privately funded biotech start-up company incorporated in 2011. The company is developing novel oral therapeutics for Alzheimer’s and Parkinson's Disease, based on a novel hypothesis and a novel mechanism of action.